David Wingfield

机构：Hammersmith Medicines Research · ORCID：0000-0001-5331-0684

发表论文 42 篇 · 总被引 1104 次 · h-index 14

代表论文

• Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial (2022 · The Lancet · 被引 412)
• SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes (2020 · Journal of Infection · 被引 260)
• Digital remote monitoring for screening and early detection of urinary tract infections (2024 · npj Digital Medicine · 被引 27)
• Novel Blood-Based Biomarkers and Disease Modifying Therapies for Alzheimer's Disease. Are We Ready for the New Era? (2024 · The Journal of Prevention of Alzheimer s Disease · 被引 22)
• Remote Monitoring of Physiology in People Living With Dementia: An Observational Cohort Study (2023 · JMIR Aging · 被引 21)
• Population incidence and associated mortality of urinary tract infection in people living with dementia (2024 · Journal of Infection · 被引 20)